Tesmilifene Hydrochloride

N/A

Report date: 2022/11/25 17:42:19
NME

Base Information

Drug NameTesmilifene Hydrochloride
Drug Alias NameTesmilifeno替米利芬TesmilifenumBMY-33419BMS-217380 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEstrogen receptors antagonistsHistamine receptor antagonists
TargetsEstrogen receptorsHistamine receptor
Therapy Area/IndicationsMetastatic breast cancerNeoplasm MetastasisBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUkraineSerbiaRussian Federation +[5] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGilead Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesYM BioSciences Inc
Active IndicationsN/A
Inactive IndicationsMetastatic breast cancerNeoplasm MetastasisBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksDrugBankKEGG